Vitamins, Cofactors, And Nutrition - USMLE Step 1

SECTION 1

Historical Context & Motivation

The recognition that specific dietary components are essential for health arose from centuries of observation of deficiency diseases. Sailors on long voyages developed scurvy, prisoners subsisting on polished rice suffered from beriberi, and populations dependent on corn as a staple developed pellagra. These clinical observations, long before the molecular era, established that food contained something beyond macronutrients—trace organic factors without which normal physiology collapsed. The systematic identification of these factors, now known as vitamins, represents one of the great triumphs of biochemistry and nutrition science, directly connecting dietary intake to enzymatic function and clinical disease.

1747 • Lind's Scurvy Trials

James Lind conducted one of the first controlled clinical trials aboard HMS Salisbury, demonstrating that citrus fruits cured scurvy—decades before vitamin C was isolated.

1897 • Eijkman and Beriberi

Christiaan Eijkman observed that chickens fed polished rice developed polyneuritis resembling beriberi, implicating a missing factor in the rice husk—later identified as thiamine (vitamin B₁).

1912 • Funk Coins 'Vitamine'

Casimir Funk proposed the term 'vitamine' (vital amine) for the anti-beriberi factor he isolated, establishing the conceptual framework that essential organic micronutrients exist in food.

1928–1937 • Isolation of Key Vitamins

Albert Szent-Györgyi isolated ascorbic acid (vitamin C), and multiple laboratories characterized the B-complex vitamins, vitamin A, and vitamin D, enabling the modern classification of water-soluble and fat-soluble vitamins.

1950s–Present • Molecular Mechanisms Elucidated

Advances in enzymology and X-ray crystallography revealed how vitamins function as cofactors and coenzymes, linking deficiency syndromes to specific metabolic blocks—the biochemical basis tested on USMLE Step 1.

The central question that this lesson addresses is: how do vitamins, once ingested, become the cofactors and coenzymes that drive enzymatic catalysis, and what clinical consequences arise when these pathways are disrupted? Understanding this biochemical logic is essential for interpreting deficiency syndromes, drug–nutrient interactions, and the metabolic questions that appear throughout USMLE Step 1.

SECTION 2

Core Principles & Definitions

Before diving into individual vitamins, it is essential to establish the foundational terminology and classification principles that organize this vast topic. Vitamins are organic compounds required in trace amounts that cannot be synthesized in sufficient quantities by the human body and must therefore be obtained from the diet. They are distinguished from macronutrients (carbohydrates, lipids, proteins) by the small quantities needed—typically micrograms to milligrams per day. Vitamins function primarily by serving as precursors to coenzymes or cofactors that enable enzymatic reactions central to intermediary metabolism, biosynthesis, and cellular signaling.

Water-Soluble vs. Fat-Soluble

Water-soluble vitamins (B-complex, C) are absorbed in the intestine and excreted renally; excess is not significantly stored. Fat-soluble vitamins (A, D, E, K) require bile salts for absorption, are stored in adipose tissue and liver, and can accumulate to toxic levels.

Cofactors vs. Coenzymes

A cofactor is any non-protein chemical compound required for enzyme activity; it may be a metal ion (Zn²⁺, Mg²⁺) or an organic molecule. When the cofactor is organic and derived from a vitamin, it is specifically termed a coenzyme (e.g., NAD⁺ from niacin, FAD from riboflavin).

Prosthetic Groups vs. Cosubstrates

Prosthetic groups (e.g., FAD, biotin) are tightly or covalently bound to the enzyme and regenerated in situ. Cosubstrates (e.g., NAD⁺, coenzyme A) bind transiently, are chemically altered during the reaction, and must be regenerated by separate reactions.

Deficiency vs. Toxicity

Clinical disease results from both deficiency and excess. Water-soluble vitamin toxicity is rare (exception: B₆ neuropathy). Fat-soluble vitamin toxicity (hypervitaminosis A, D) can be severe because hepatic and adipose storage allows accumulation.

Holoenzyme = Apoenzyme + Cofactor

The apoenzyme is the protein portion alone, which is catalytically inactive. Only when the appropriate cofactor or coenzyme binds does the holoenzyme—the functional catalytic unit—form. Vitamin deficiency reduces holoenzyme formation, producing metabolic blocks.

✦

KEY TAKEAWAY

Think of an enzyme as a power tool and the vitamin-derived coenzyme as the battery. The tool (apoenzyme) has the correct shape and mechanism, but without the battery (coenzyme), it cannot perform work. Vitamin deficiency is essentially a 'dead battery' scenario—the enzyme protein is present but catalytically inert. This analogy explains why deficiency diseases map so precisely to specific metabolic pathways.

SECTION 3

Visual Overview of Vitamin Classification & Function

This diagram categorizes all thirteen essential vitamins into water-soluble (left, cyan) and fat-soluble (right, amber) groups. Each vitamin is paired with its active cofactor form and the key enzymatic reactions it participates in. Note the clinical note at the bottom: fat-soluble vitamin deficiency is a hallmark of fat malabsorption syndromes such as cystic fibrosis, celiac disease, and bile duct obstruction.

The diagram above provides a one-glance reference for the vitamin-to-cofactor conversions that USMLE Step 1 expects you to know. Water-soluble vitamins predominantly function as coenzymes in energy metabolism and one-carbon transfer reactions—hence their involvement in the citric acid cycle, fatty acid oxidation, and nucleotide synthesis. Fat-soluble vitamins, by contrast, tend to function in signaling, structural integrity, and specialized post-translational modifications. A practical clinical correlate is that conditions causing fat malabsorption—such as cystic fibrosis, celiac disease, chronic pancreatitis, or cholestatic liver disease—selectively deplete the fat-soluble vitamins (A, D, E, K) while sparing the water-soluble ones.

SECTION 4

Mechanisms of Cofactor Action

To understand vitamin biochemistry at the USMLE level, you need to grasp how cofactors participate mechanistically in enzymatic reactions. Rather than memorizing every enzyme, focus on the chemical logic of each cofactor—what type of chemistry it enables. This section walks through the major mechanistic categories.

Redox Cofactors: NAD⁺/NADH and FAD/FADH₂

NAD⁺ (from niacin, B₃) and FAD (from riboflavin, B₂) are the cell's principal electron shuttles. NAD⁺ accepts a hydride ion (H⁻) to become NADH, which carries electrons to Complex I of the electron transport chain. FAD accepts two hydrogen atoms to become FADH₂, entering the ETC at Complex II. The key distinction: NAD⁺ is a freely diffusible cosubstrate, while FAD is typically a tightly bound prosthetic group. NADP⁺, the phosphorylated form, is used primarily in anabolic reductive biosynthesis (fatty acid synthesis, steroid synthesis, glutathione reduction).

NAD⁺ REDUCTION

NAD⁺ + 2H → NADH + H⁺

NAD⁺ accepts a hydride ion (one proton + two electrons) from the substrate; the second proton is released into solution. Each NADH yields approximately 2.5 ATP via oxidative phosphorylation.

Group Transfer Cofactors

Several B vitamins generate cofactors that transfer specific chemical groups. Thiamine pyrophosphate (TPP) from B₁ transfers activated aldehyde groups, functioning in oxidative decarboxylation of α-keto acids (pyruvate dehydrogenase, α-ketoglutarate dehydrogenase) and in the transketolase reaction of the pentose phosphate pathway. Coenzyme A (CoA) from pantothenate (B₅) transfers acyl groups via a thioester bond—critical in the citric acid cycle (acetyl-CoA), fatty acid synthesis, and amino acid metabolism. Tetrahydrofolate (THF) from folate (B₉) transfers one-carbon units (methyl, methylene, formyl groups) essential for purine and thymidine synthesis. Pyridoxal phosphate (PLP) from B₆ participates in transamination, decarboxylation, and racemization of amino acids by stabilizing a carbanion intermediate through a Schiff base with the amino acid substrate.

CARBOXYLATION BY BIOTIN

Biotin−enzyme + CO₂ + ATP → Carboxybiotin−enzyme + ADP + Pᵢ

Biotin (B₇) is a prosthetic group covalently attached via a lysine residue. It activates CO₂ for transfer to substrates. Key enzymes: pyruvate carboxylase (gluconeogenesis), acetyl-CoA carboxylase (fatty acid synthesis), propionyl-CoA carboxylase (odd-chain fatty acid metabolism).

Antioxidant and Hydroxylation Functions

Vitamin C (ascorbic acid) serves as a reducing agent for prolyl and lysyl hydroxylase—enzymes that hydroxylate proline and lysine residues in collagen, stabilizing the triple helix. Without adequate vitamin C, underhydroxylated collagen is structurally weak, producing the fragile blood vessels, poor wound healing, and gum disease of scurvy. Vitamin C also maintains iron in the Fe²⁺ state required by these dioxygenases and enhances nonheme iron absorption in the gut. Vitamin E (α-tocopherol), residing in lipid bilayers, terminates lipid peroxidation chain reactions by donating a hydrogen atom to lipid peroxyl radicals, protecting polyunsaturated fatty acids in cell membranes from oxidative damage.

⚠

Clinical Pearl

Isoniazid (INH), a first-line anti-tuberculosis drug, depletes pyridoxal phosphate (PLP) by forming inactive hydrazones. Patients on INH must receive B₆ supplementation to prevent peripheral neuropathy and sideroblastic anemia—a high-yield USMLE association.

SECTION 5

Deficiency Syndromes & Clinical Correlations

One of the most heavily tested areas on USMLE Step 1 is the association between specific vitamin deficiencies and their clinical presentations. The logic is straightforward: if you understand which metabolic pathway a vitamin supports, you can predict the clinical syndrome that emerges when it is absent. The table below serves as a comprehensive, high-yield reference linking each vitamin to its deficiency disease, key clinical features, and the biochemical mechanism underlying the pathology.

Vitamin	Deficiency Syndrome	Key Clinical Features	Biochemical Basis
B₁ (Thiamine)	Beriberi (wet/dry), Wernicke-Korsakoff syndrome	Wet: high-output cardiac failure, edema. Dry: peripheral neuropathy. Wernicke: confusion, ophthalmoplegia, ataxia. Korsakoff: confabulation, memory loss	Impaired pyruvate DH → lactic acidosis; impaired α-KG DH; reduced transketolase (RBC assay)
B₂ (Riboflavin)	Ariboflavinosis	Cheilosis (cracking at mouth corners), glossitis, corneal vascularization	Reduced FAD/FMN → impaired ETC and fatty acid oxidation
B₃ (Niacin)	Pellagra	3 D's: Diarrhea, Dermatitis (sun-exposed, Casal necklace), Dementia; can progress to Death (4th D)	↓ NAD⁺/NADP⁺ → widespread metabolic failure. Tryptophan → niacin pathway requires B₆, B₂, Fe
B₅ (Pantothenate)	Rare ("burning feet syndrome")	Dermatitis, enteritis, adrenal insufficiency, paresthesias	↓ CoA → impaired acyl transfers in TCA cycle and fatty acid metabolism
B₆ (Pyridoxine)	Peripheral neuropathy, sideroblastic anemia	Convulsions (↓ GABA synthesis), microcytic anemia (↓ heme synthesis via ALA synthase), cheilosis	↓ PLP → impaired transamination, decarboxylation; INH is a common cause
B₇ (Biotin)	Rare; seen with raw egg white consumption	Dermatitis, alopecia, enteritis	Avidin in raw egg whites binds biotin; ↓ carboxylase activity
B₉ (Folate)	Megaloblastic anemia, neural tube defects	Macrocytic anemia, hypersegmented neutrophils, ↑ homocysteine, normal methylmalonic acid	↓ THF → impaired dTMP synthesis → impaired DNA synthesis → megaloblastic change
B₁₂ (Cobalamin)	Megaloblastic anemia + neurologic disease	Same as folate deficiency PLUS subacute combined degeneration (dorsal columns, lateral corticospinal tracts); ↑ homocysteine AND ↑ methylmalonic acid	Methyl trap hypothesis: ↓ B₁₂ → THF trapped as N⁵-methyl-THF → functional folate deficiency; ↓ methylmalonyl-CoA mutase → ↑ MMA
C (Ascorbic acid)	Scurvy	Swollen gums, perifollicular hemorrhages, poor wound healing, corkscrew hairs, easy bruising	↓ prolyl/lysyl hydroxylase → defective collagen cross-linking
A (Retinol)	Night blindness, xerophthalmia, Bitot spots	Night blindness (earliest), dry eyes (xerophthalmia), keratomalacia, immune dysfunction, follicular hyperkeratosis	Retinal is chromophore in rhodopsin; retinoic acid regulates gene expression for epithelial differentiation
D (Cholecalciferol)	Rickets (children), Osteomalacia (adults)	Rickets: bowed legs, craniotabes, rachitic rosary. Osteomalacia: bone pain, fractures, proximal muscle weakness	↓ 1,25-(OH)₂D₃ → ↓ intestinal Ca²⁺/PO₄³⁻ absorption → ↓ mineralization → soft bones
E (Tocopherol)	Hemolytic anemia, neuromuscular disease	Hemolytic anemia (esp. premature infants), posterior column and spinocerebellar tract degeneration, retinitis pigmentosa	↓ antioxidant protection → lipid peroxidation of RBC and neuronal membranes
K (Phylloquinone)	Hemorrhagic disease of the newborn, coagulopathy	↑ PT/INR, easy bruising, bleeding; neonates at risk (sterile gut, low stores)	↓ γ-carboxylation of glutamate residues on clotting factors II, VII, IX, X and proteins C & S

Comprehensive vitamin deficiency table for USMLE Step 1 review

This pathway diagram illustrates the interplay between folate and vitamin B₁₂ in one-carbon metabolism. The methyl trap hypothesis explains why B₁₂ deficiency produces a functional folate deficiency: without B₁₂-dependent methionine synthase, N⁵-methyl-THF cannot donate its methyl group and THF cannot be regenerated. Note that methotrexate inhibits DHF reductase, explaining its anti-folate mechanism of action. The distinguishing laboratory finding between folate and B₁₂ deficiency is elevated methylmalonic acid, which is only seen in B₁₂ deficiency due to impaired methylmalonyl-CoA mutase.

⚠

High-Yield Distinction

Both folate and B₁₂ deficiency cause megaloblastic anemia with hypersegmented neutrophils and elevated homocysteine. The key differentiator is methylmalonic acid (MMA): elevated in B₁₂ deficiency (due to impaired methylmalonyl-CoA mutase), normal in folate deficiency. B₁₂ deficiency also uniquely causes subacute combined degeneration of the spinal cord—dorsal columns (loss of vibration/proprioception) and lateral corticospinal tracts (upper motor neuron signs).

SECTION 6

Worked Clinical Vignette

USMLE Step 1 frequently presents vitamin-related questions as clinical vignettes requiring you to integrate the patient's history, physical examination, and laboratory findings to identify the specific vitamin deficiency and its biochemical mechanism. Let's work through a representative example step by step.

Clinical Vignette: Chronic Alcoholic with Neurologic Symptoms

1
Step 1 — Read the Stem Carefully

A 55-year-old man with a long history of alcohol abuse is brought to the emergency department by his family. He is confused, has difficulty walking with a broad-based ataxic gait, and on examination has bilateral lateral rectus palsy (inability to abduct either eye). His nutritional status appears poor. Before administering IV dextrose, the attending physician orders an urgent IV infusion of a specific vitamin.
2
Step 2 — Identify the Clinical Triad

The three cardinal features presented are: (1) confusion (encephalopathy), (2) ataxia (gait instability), and (3) ophthalmoplegia (lateral rectus palsy). This is the classic triad of Wernicke encephalopathy.

Wernicke triad: Confusion + Ataxia + Ophthalmoplegia
3
Step 3 — Link to Vitamin Deficiency

Wernicke encephalopathy is caused by thiamine (vitamin B₁) deficiency. Chronic alcohol use leads to thiamine deficiency through multiple mechanisms: poor dietary intake, impaired intestinal absorption, decreased hepatic storage, and increased utilization. Thiamine pyrophosphate (TPP) is the active cofactor for pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase, and transketolase.

Vitamin B₁ (thiamine) deficiency → ↓ TPP
4
Step 4 — Explain the Biochemical Mechanism

Without TPP, pyruvate dehydrogenase cannot convert pyruvate to acetyl-CoA, leading to impaired aerobic glucose metabolism. The brain, which is exquisitely dependent on glucose oxidation, is particularly vulnerable. Certain brain regions—the mammillary bodies, periaqueductal gray, and medial thalamus—are selectively affected, producing the characteristic neurological findings. If untreated, Wernicke encephalopathy may progress to Korsakoff syndrome (irreversible confabulation and anterograde amnesia due to mammillary body damage).
5
Step 5 — Answer the Management Question

The physician ordered IV thiamine BEFORE administering IV dextrose. This is critical because glucose metabolism requires TPP; administering glucose to a thiamine-depleted patient can acutely worsen Wernicke encephalopathy by consuming the last remaining thiamine stores. This is an extremely high-yield USMLE management principle.

Always give thiamine BEFORE glucose in suspected Wernicke encephalopathy

SECTION 7

Toxicity Syndromes & Drug–Nutrient Interactions

While deficiency syndromes dominate USMLE questioning, toxicity and drug–nutrient interactions are also high-yield. Understanding both sides of the coin—too little and too much—is essential for clinical reasoning. The following table summarizes key toxicity syndromes and the most commonly tested drug interactions affecting vitamin metabolism.

Vitamin / Drug	Toxicity or Interaction	Mechanism & Clinical Significance
Vitamin A (excess)	Hypervitaminosis A	Hepatotoxicity, pseudotumor cerebri (↑ ICP), skin desquamation, teratogenicity (isotretinoin). Stored in hepatic stellate (Ito) cells; excess → hepatic fibrosis.
Vitamin D (excess)	Hypercalcemia	Excessive intestinal Ca²⁺ absorption → hypercalcemia → kidney stones, metastatic calcification, confusion, constipation ("stones, bones, groans, and psychiatric moans").
Vitamin B₆ (excess)	Sensory neuropathy	Megadose supplementation (>200 mg/day) causes dose-dependent peripheral sensory neuropathy. Unique among water-soluble vitamins for clinically significant toxicity.
Niacin (pharmacologic)	Flushing, hepatotoxicity, hyperglycemia, hyperuricemia	At pharmacologic doses (for dyslipidemia), niacin causes prostaglandin-mediated cutaneous flushing (blocked by aspirin), can worsen gout and diabetes.
Isoniazid → B₆	INH-induced B₆ depletion	INH forms hydrazones with PLP → peripheral neuropathy, sideroblastic anemia. Prophylactic B₆ supplementation required.
Methotrexate → Folate	DHF reductase inhibition	Methotrexate inhibits dihydrofolate reductase → ↓ THF → megaloblastic anemia, mucositis, myelosuppression. Leucovorin (folinic acid) rescue provides THF directly, bypassing the block.
Warfarin → Vitamin K	Vitamin K epoxide reductase inhibition	Warfarin inhibits VKORC1 → ↓ reduced vitamin K → ↓ γ-carboxylation of factors II, VII, IX, X and proteins C, S → anticoagulation. Vitamin K is the antidote for warfarin toxicity.
Phenytoin → Folate	↓ Folate absorption/metabolism	Chronic phenytoin use impairs intestinal folate absorption and accelerates folate metabolism → megaloblastic anemia. Pregnant women on phenytoin need folate supplementation to prevent neural tube defects.

High-yield vitamin toxicities and drug–nutrient interactions

✦

KEY TAKEAWAY

Think of drug–nutrient interactions as a factory saboteur. Methotrexate is like locking the door to the THF production line (DHF reductase), while leucovorin rescue is like airlifting in pre-made THF through the back entrance. Warfarin disables the vitamin K recycling plant (VKORC1), and the antidote is simply resupplying fresh vitamin K. Understanding these interactions as supply chain disruptions makes them intuitive rather than a memorization burden.

SECTION 8

Connections to Advanced Topics

Vitamin and cofactor biochemistry is not an isolated USMLE topic—it intersects deeply with genetics, pharmacology, pathology, and clinical medicine. Mastering these connections elevates your understanding from rote memorization to integrated clinical reasoning. Several advanced concepts build directly on the foundational vitamin biochemistry discussed in this lesson.

Foundational Concept	Advanced Connection	USMLE Relevance
TPP and pyruvate dehydrogenase	Pyruvate dehydrogenase complex deficiency (genetic); arsenic poisoning (lipoic acid cofactor inhibition)	X-linked; lactic acidosis in neonate; garlic breath with arsenic
NAD⁺ from niacin; tryptophan → niacin pathway	Hartnup disease (↓ tryptophan absorption) and carcinoid syndrome (↑ tryptophan → serotonin, ↓ niacin)	Both present with pellagra-like symptoms due to niacin depletion via different mechanisms
Folate/B₁₂ and homocysteine metabolism	Homocystinuria (CBS deficiency, MTHFR variants); hyperhomocysteinemia as cardiovascular risk factor	CBS deficiency: ↑ homocysteine, ↓ cystathionine; some forms B₆-responsive. MTHFR 677C→T polymorphism increases NTD risk.
Vitamin D metabolism	Vitamin D-dependent rickets type I (1α-hydroxylase deficiency) vs. type II (VDR mutation)	Type I responds to calcitriol; Type II does not (end-organ resistance)
Vitamin K and γ-carboxylation	Warfarin pharmacology and pharmacogenomics (CYP2C9, VKORC1 polymorphisms)	Genetic variants alter warfarin dose requirements; tested in pharmacology and genetics contexts
B₁₂ absorption (IF, terminal ileum)	Pernicious anemia (anti-IF antibodies); Crohn disease/ileal resection; Diphyllobothrium latum (fish tapeworm)	Multiple causes of B₁₂ deficiency with different mechanisms: autoimmune, surgical, parasitic

Connections between vitamin biochemistry and advanced USMLE topics

As you advance through your USMLE preparation, you will encounter these same vitamins and cofactors in the contexts of inborn errors of metabolism, pharmacology (drug mechanisms and side effects), pathology (disease presentations), and even microbiology (the role of gut flora in vitamin K and biotin synthesis). The biochemistry of vitamins and cofactors thus functions as a cross-disciplinary backbone that integrates multiple subject areas—precisely the kind of integrative thinking that USMLE Step 1 rewards.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A patient with chronic alcoholism presents with high-output cardiac failure, peripheral edema, and elevated lactate. Which vitamin deficiency is most likely responsible, and what is the biochemical mechanism linking this deficiency to lactic acidosis?

Show answer

This presentation is consistent with wet beriberi caused by thiamine (vitamin B₁) deficiency. Thiamine pyrophosphate (TPP) is a required cofactor for pyruvate dehydrogenase, which converts pyruvate to acetyl-CoA. Without TPP, pyruvate accumulates and is shunted to lactate via lactate dehydrogenase, causing lactic acidosis. The high-output cardiac failure results from peripheral vasodilation and impaired cardiac energy metabolism. Chronic alcohol use causes thiamine deficiency through poor dietary intake, impaired intestinal absorption, decreased hepatic storage, and impaired phosphorylation to TPP.

Question 2: BASIC CALCULATION

A laboratory report shows that a patient's RBC transketolase activity increases by 30% after in vitro addition of TPP. A normal TPP effect is <15%. Which vitamin is deficient, and which metabolic pathway does transketolase participate in?

Show answer

The RBC transketolase activation assay (also called the TPP effect) is the standard functional test for thiamine (B₁) status. A >25% increase in transketolase activity after TPP addition indicates significant thiamine deficiency. Transketolase is a key enzyme in the non-oxidative phase of the pentose phosphate pathway (hexose monophosphate shunt), which transfers 2-carbon units between sugar phosphates. This pathway generates NADPH for reductive biosynthesis and ribose-5-phosphate for nucleotide synthesis. The 30% activation in this patient exceeds the 15% normal cutoff, confirming thiamine deficiency.

Question 3: INTERMEDIATE

A 28-year-old woman on treatment for tuberculosis with isoniazid develops numbness and tingling in her hands and feet. Laboratory studies reveal a microcytic anemia with ringed sideroblasts on bone marrow biopsy. Which vitamin deficiency explains both findings, and what is the mechanism of the sideroblastic anemia?

Show answer

Isoniazid depletes pyridoxal phosphate (PLP), the active form of vitamin B₆, by forming inactive hydrazones. PLP deficiency explains both the peripheral neuropathy (impaired neurotransmitter synthesis, particularly GABA) and the sideroblastic anemia. PLP is a required cofactor for aminolevulinic acid (ALA) synthase, the first and rate-limiting enzyme of heme biosynthesis. When ALA synthase activity is reduced, heme production decreases, and iron continues to be imported into mitochondria but cannot be incorporated into protoporphyrin IX. The excess iron deposits in mitochondria, forming the characteristic perinuclear ring of iron-laden mitochondria visible as ringed sideroblasts on Prussian blue stain. This is the most common cause of drug-induced sideroblastic anemia, and B₆ supplementation is standard prophylaxis for patients on INH.

Question 4: APPLIED

A 60-year-old woman with a history of Crohn disease involving the terminal ileum presents with fatigue, glossitis, and unsteady gait. CBC reveals macrocytic anemia with hypersegmented neutrophils. Serum homocysteine is elevated. How would you distinguish between folate deficiency and vitamin B₁₂ deficiency in this patient, and which is more likely given her history?

Show answer

Both folate and B₁₂ deficiency cause megaloblastic anemia with hypersegmented neutrophils and elevated homocysteine. The key distinguishing test is serum methylmalonic acid (MMA): it is elevated in B₁₂ deficiency (because B₁₂ is a cofactor for methylmalonyl-CoA mutase) but normal in isolated folate deficiency. Given this patient's Crohn disease involving the terminal ileum, B₁₂ deficiency is far more likely because the terminal ileum is the exclusive site of B₁₂-intrinsic factor complex absorption. Folate is absorbed in the proximal jejunum and would not be affected by terminal ileal disease. The unsteady gait raises concern for subacute combined degeneration of the spinal cord (dorsal column and lateral corticospinal tract demyelination), which is unique to B₁₂ deficiency and does not occur with isolated folate deficiency. You should order serum B₁₂, folate, and MMA levels; anticipate low B₁₂, elevated MMA, and elevated homocysteine in this patient.

Question 5: CRITICAL THINKING

A well-meaning physician discovers that a patient with megaloblastic anemia and neurologic symptoms has low B₁₂ and starts the patient on high-dose oral folate supplementation alone, without B₁₂ replacement. Explain, using the methyl trap hypothesis, why this approach could partially correct the anemia but worsen the neurologic damage, and discuss the biochemical basis for this dangerous clinical scenario.

Show answer

In B₁₂ deficiency, the methyl trap occurs because methionine synthase (which requires B₁₂) cannot convert N⁵-methyl-THF back to THF. Folate becomes trapped in the N⁵-methyl-THF form, creating a functional folate deficiency that impairs dTMP synthesis and causes megaloblastic anemia. If high-dose folate is administered without B₁₂, it can bypass the methyl trap by providing excess substrate that partially restores dTMP synthesis through alternative pathways, thereby improving the hematologic picture. However, this masks the underlying B₁₂ deficiency while doing nothing to address the neurologic damage. The neurologic deterioration in B₁₂ deficiency results from impaired methylmalonyl-CoA mutase activity (leading to accumulation of methylmalonic acid and odd-chain fatty acids that are incorporated into myelin, destabilizing it) and from inadequate SAM-dependent methylation reactions needed for myelin maintenance. Folate supplementation does not correct either of these B₁₂-dependent processes. Thus, the anemia improves while the subacute combined degeneration of the spinal cord progresses silently or worsens—potentially irreversibly. This is precisely why current guidelines mandate that folate supplementation should never be given without first excluding B₁₂ deficiency, and it explains why USMLE Step 1 emphasizes checking both folate and B₁₂ levels before initiating treatment for megaloblastic anemia.

SUMMARY

Summary & Key Concepts

Summary

Vitamins are essential organic micronutrients classified as water-soluble (B-complex, C) or fat-soluble (A, D, E, K). Water-soluble vitamins are absorbed intestinally and excreted renally with low toxicity risk, while fat-soluble vitamins require bile salts for absorption and accumulate in liver and adipose tissue, creating toxicity risk (especially A and D). Most vitamins function as precursors to coenzymes and cofactors that enable enzymatic reactions: NAD⁺/FAD for redox reactions, TPP for oxidative decarboxylation, PLP for amino acid transformations, THF for one-carbon transfers, and CoA for acyl group transfers.

Clinically, each deficiency produces a predictable syndrome: B₁ → Wernicke-Korsakoff/beriberi, B₃ → pellagra, B₉/B₁₂ → megaloblastic anemia (with B₁₂ uniquely causing subacute combined degeneration and elevated MMA), C → scurvy, D → rickets/osteomalacia, and K → coagulopathy. High-yield drug interactions include isoniazid → B₆ depletion, methotrexate → folate antagonism, and warfarin → vitamin K cycle inhibition. The methyl trap hypothesis explains the dangerous practice of treating B₁₂ deficiency with folate alone, and the principle of giving thiamine before glucose in suspected Wernicke encephalopathy remains one of the most tested clinical management pearls on USMLE Step 1.